Psychedelic drugs were a hot topic at this year's Society for Neuroscience meeting. Researchers hope the drugs can help people with disorders like depression and PTSD.
In a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.
Gerald Miles' anxiety and depression was constant and crippling. Modern treatments weren't helping. But electroconvulsive therapy, an older, controversial method, did.
Ketamine, a Schedule III non-narcotic substance, has been available to licensed prescribers since the 1970s. Since then, multiple studies have shown ketamine helps some depression patients who feel as though they’ve tried everything else.
Scientists are using MRI scans to understand how mental illness shows up in the bran. But new research raises concerns that existing studies are not reliable because the sample sizes are too small.
The remedy is a new type of transcranial magnetic stimulation that's showing good results in just five days of treatment. For some patients, it's life-changing.
Even when mental health is covered, providers of behavioral health services can be tough to find. And there are not always enough of them to treat rising pandemic-related anxiety or depression.
The deadline to sign up for a health plan on the marketplace is Jan. 15.
Three leading pediatric health organizations are sounding the alarm about "soaring rates" of depression, anxiety and suicidal thoughts among children and adolescents.
The pandemic has made people more open to seeking help, a new survey finds, but cost and difficulty in finding a mental health care provider are still big obstacles.
A new CDC study finds that people who provide unpaid care for their children or adult loved ones are twice as likely as noncaregivers to have experienced depression or anxiety, or thoughts of suicide.
What can you do when you fear someone you know may be considering suicide? It can feel daunting, but suicide prevention experts say we all can help someone at risk by reaching out and showing we care.
A synthetic version of the psychedelic drug ibogaine appears to relieve depression and addiction without producing hallucinations or other dangerous side effects — at least in rodents.
Youth depression, anxiety and suicide attempts have been on the rise during the pandemic. School shutdowns keep kids from friends and therapists, leaving social growth up to parents in many cases.
